Come join others currently navigating treatment in our weekly Virtual Support Groups! See times and register here.

Treatment After CDK4/6 Inhibitors

moderators
moderators Posts: 9,647
edited December 2023 in Targeted Therapy - Before, During, and After
Graff_TreatmentAfterCDK46Inhibitors_2466x1644.png

Treatment After CDK4/6 Inhibitors

Dec 5, 2023

Medical oncologist Stephanie Graff explains the treatment options available after a CDK4/6 inhibitor stops working.

CDK4/6 inhibitors are used to treat both early-stage and advanced-stage hormone receptor-positive, HER2-negative breast cancer. 

The CDK4/6 inhibitors are:

At the 2023 San Antonio Breast Cancer Symposium, Dr. Stephanie Graff moderated an educational session to help people and their doctors decide on treatments after a CDK4/6 inhibitor has stopped working.

Listen to the podcast to hear Dr. Graff explain:

  • how the oral SERD, Orserdu (chemical name: elacestrant), might be used
  • how PARP inhibitors, such as Lynparza (chemical name: olaparib) or Talzenna (chemical name: talazoparib) might be used
  • why using a CDK4/6 inhibitor after another CDK4/6 inhibitor probably won’t be used

Listen now or read the transcript.

Tagged:

Categories

Join Us on Zoom: Upcoming virtual support groups. Read more...
Share more about you! Fill out your NEW profile.